160 related articles for article (PubMed ID: 30478420)
1. FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas.
Grupp K; Uzunoglu FG; Melling N; Hofmann B; El Gammal AT; Grotelüschen R; Heumann A; Bellon E; Reeh M; Wolters-Eisfeld G; Ghabdan T; Nentwich M; Bachmann K; Bockhorn M; Bogoevski D; Izbicki JR; Kutup A
Sci Rep; 2018 Nov; 8(1):17370. PubMed ID: 30478420
[TBL] [Abstract][Full Text] [Related]
2. High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients.
El Gammal AT; Melling N; Reeh M; Gebauer F; Mann O; Perez D; Bockhorn M; Bachmann K; Izbicki JR; Grupp K
Exp Mol Pathol; 2019 Apr; 107():51-56. PubMed ID: 30707896
[TBL] [Abstract][Full Text] [Related]
3. Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients.
Bellon E; Grupp K; Ghadban T; Tachezy M; Bachmann K; Izbicki JR; Simon R; Sauter G; Hube-Magg C; Melling N
J Cancer Res Clin Oncol; 2021 Oct; 147(10):2879-2884. PubMed ID: 34148155
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of Sec61α in esophageal cancers.
Bachmann K; Bockhorn M; Mann O; Gebauer F; Blessmann M; Izbicki JR; Grupp K
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2039-2044. PubMed ID: 31197453
[TBL] [Abstract][Full Text] [Related]
5. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of microRNA-1288 in oesophageal squamous cell carcinoma.
Gopalan V; Islam F; Pillai S; Tang JC; Tong DK; Law S; Chan KW; Lam AK
Exp Cell Res; 2016 Nov; 348(2):146-154. PubMed ID: 27658568
[TBL] [Abstract][Full Text] [Related]
7. Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma.
Rosato A; Pivetta M; Parenti A; Iaderosa GA; Zoso A; Milan G; Mandruzzato S; Del Bianco P; Ruol A; Zaninotto G; Zanovello P
Int J Cancer; 2006 Oct; 119(7):1717-22. PubMed ID: 16671090
[TBL] [Abstract][Full Text] [Related]
8. EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer.
Fichter CD; Timme S; Braun JA; Gudernatsch V; Schöpflin A; Bogatyreva L; Geddert H; Faller G; Klimstra D; Tang L; Hauschke D; Werner M; Lassmann S
Int J Cancer; 2014 Oct; 135(7):1517-30. PubMed ID: 24510732
[TBL] [Abstract][Full Text] [Related]
9. Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.
Grupp K; Hofmann B; Kutup A; Bachmann K; Bogoevski D; Melling N; Uzunoglu FG; El Gammal AT; Koop C; Simon R; Steurer S; Krech T; Burdak-Rothkamm S; Jacobsen F; Sauter G; Izbicki J; Wilczak W
BMC Cancer; 2018 Nov; 18(1):1106. PubMed ID: 30419865
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.
Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D
Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
[TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
14. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.
Altan B; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Kogure N; Kimura A; Hara K; Bai T; Bao P; Suzuki M; Ogata K; Asao T; Nishiyama M; Oyama T; Kuwano H
Gastric Cancer; 2016 Jul; 19(3):789-97. PubMed ID: 26472729
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
Kalinina T; Bockhorn M; Kaifi JT; Thieltges S; Güngör C; Effenberger KE; Strelow A; Reichelt U; Sauter G; Pantel K; Izbicki JR; Yekebas EF
Int J Cancer; 2010 Oct; 127(8):1931-40. PubMed ID: 20104520
[TBL] [Abstract][Full Text] [Related]
16. FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma.
Xiao Z; Jia Y; Jiang W; Wang Z; Zhang Z; Gao Y
Thorac Cancer; 2018 Aug; 9(8):997-1004. PubMed ID: 29877046
[TBL] [Abstract][Full Text] [Related]
17. Programmed cell death 4 protein in esophageal cancer.
Fassan M; Cagol M; Pennelli G; Rizzetto C; Giacomelli L; Battaglia G; Zaninotto G; Ancona E; Ruol A; Rugge M
Oncol Rep; 2010 Jul; 24(1):135-9. PubMed ID: 20514454
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
[TBL] [Abstract][Full Text] [Related]
19. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma.
Agrawal N; Jiao Y; Bettegowda C; Hutfless SM; Wang Y; David S; Cheng Y; Twaddell WS; Latt NL; Shin EJ; Wang LD; Wang L; Yang W; Velculescu VE; Vogelstein B; Papadopoulos N; Kinzler KW; Meltzer SJ
Cancer Discov; 2012 Oct; 2(10):899-905. PubMed ID: 22877736
[TBL] [Abstract][Full Text] [Related]
20. miR-486-5p expression pattern in esophageal squamous cell carcinoma, gastric cancer and its prognostic value.
Ren C; Chen H; Han C; Fu D; Zhou L; Jin G; Wang F; Wang D; Chen Y; Ma L; Zheng X; Han D
Oncotarget; 2016 Mar; 7(13):15840-53. PubMed ID: 26895105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
